Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients.

Mozaffari, Shilan; Nikfar, Shekoufeh; Abdollahi, Mohammad

Mozaffari, Shilan; Nikfar, Shekoufeh; Abdollahi, Mohammad.

Afiliación

Mozaffari S; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Nikfar S; Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran ; Iranian Food and Drug Administration, Ministry of Health and Medical Education, Tehran, Iran.
Abdollahi M; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran ; Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Arch Med Sci ; 10(1): 10-8, 2014 Feb 24.

Article en En | MEDLINE | ID: mdl-24701208

Palabras clave

5-hydroxytryptamine; clinical trial; irritable bowel syndrome; meta-analysis; renzapride; systematic review

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Systematic_reviews Idioma: En Revista: Arch Med Sci Año: 2014 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google